The most harmful scenario is having gene variants that reduce glutathione levels and high toxin levels that deplete glutathione
File File history File usage on Commons Original file (375 659 pixels, file size: 45 KB, MIME type: image/jpeg) File information Structured data Captions Captions Add a one-line explanation of what this file represents I, the copyright holder of this work, hereby publish it under the following license: You are free: to share to copy, distribute and transmit the work to remix to adapt the work Under the following conditions: attribution You must give appropriate credit, provide a link to the license, and indicate if changes were made
Stopping because symptoms improved at week 2 means abandoning the protocol before the structural repair phase has completed
What BPC-157 does at the tissue level is promote angiogenesis, the formation of new blood vessels into damaged tissue, and it activates growth hormone receptors in tendon fibroblasts, which accelerates collagen synthesis at the repair site
TB-500 (Thymosin Beta-4): , BPC-157